GSK3B and type 2 diabetes mellitus: Establishing the role of this site in vivo as well as potential functional interplay with previously identified GSK-3 sites has important implications for exploring GSK-3β as a therapeutic target to treat hyperlipidaemia of type-2 diabetes and obesity [64].